Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 pandemic-related changes in wellness behavior among older Americans.
Harrison E, Monroe-Lord L, Carson AD, Jean-Baptiste AM, Phoenix J, Jackson P, Harris BM, Asongwed E, Richardson ML. Harrison E, et al. Among authors: phoenix j. BMC Public Health. 2021 Apr 19;21(1):755. doi: 10.1186/s12889-021-10825-6. BMC Public Health. 2021. PMID: 33874931 Free PMC article.
HIV-1 Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Pooled Analysis From 72 Global Studies.
Landovitz RJ, Tao L, Yang J, de Boer M, Carter C, Das M, Baeten JM, Liu A, Hoover KW, Celum C, Grinsztejn B, Morris S, Wheeler DP, Mayer KH, Golub SA, Bekker LG, Diabaté S, Hoornenborg E, Myers J, Leech AA, McCormack S, Chan PA, Sweat M, Matthews LT, Grant R; Global F/TDF PrEP Study Team. Landovitz RJ, et al. Clin Infect Dis. 2024 Mar 14:ciae143. doi: 10.1093/cid/ciae143. Online ahead of print. Clin Infect Dis. 2024. PMID: 38484128
Gender Affirming Hormones Do Not Affect the Exposure and Efficacy of F/TDF or F/TAF for HIV Preexposure Prophylaxis: A Subgroup Analysis from the DISCOVER Trial.
Cespedes MS, Das M, Yager J, Prins M, Krznaric I, de Jong J, Xiao D, Shao Y, Wong P, Kintu A, Carter C, Hoornenborg E, Ruane P, Phoenix J, Younis I, Halperin J. Cespedes MS, et al. Among authors: phoenix j. Transgend Health. 2024 Jan 31;9(1):46-52. doi: 10.1089/trgh.2022.0048. eCollection 2024 Feb. Transgend Health. 2024. PMID: 38312459
Editorial: Hormone resistance in cancer.
Phoenix JT, Budreika A, Kostlan RJ, Hwang JH, Fanning SW, Kregel S. Phoenix JT, et al. Front Endocrinol (Lausanne). 2023 Aug 24;14:1272932. doi: 10.3389/fendo.2023.1272932. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37693345 Free PMC article. No abstract available.
37 results